Liza Bergkvist

Solna, AB 17164, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Urinary tract infections trigger synucleinopathy via the innate immune response.

Urinary tract infections trigger synucleinopathy via the innate immune response.

Journal: Acta neuropathologica

Published: December 30, 2022

Air pollution nanoparticle and alpha-synuclein fibrils synergistically decrease glutamate receptor A1, depending upon nPM batch activity.

Air pollution nanoparticle and alpha-synuclein fibrils synergistically decrease glutamate receptor A1, depending upon nPM batch activity.

Journal: Heliyon

Published: November 04, 2022

Targeting Chaperone/Co-Chaperone Interactions with Small Molecules: A Novel Approach to Tackle Neurodegenerative Diseases.

Targeting Chaperone/Co-Chaperone Interactions with Small Molecules: A Novel Approach to Tackle Neurodegenerative Diseases.

Journal: Cells

Published: September 08, 2021

Exploring Aβ Proteotoxicity and Therapeutic Candidates Using Drosophila melanogaster.

Exploring Aβ Proteotoxicity and Therapeutic Candidates Using Drosophila melanogaster.

Journal: International journal of molecular sciences

Published: August 27, 2021

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay.

Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay.

Journal: Journal of visualized experiments : JoVE

Published: August 09, 2021

Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological α-synuclein spread in the prodromal preformed fibrils model in young mice.

Heterozygous GBA D409V and ATP13a2 mutations do not exacerbate pathological α-synuclein spread in the prodromal preformed fibrils model in young mice.

Journal: Neurobiology of disease

Published: May 24, 2021

An extended release GLP-1 analogue increases α-synuclein accumulation in a mouse model of prodromal Parkinson's disease.

An extended release GLP-1 analogue increases α-synuclein accumulation in a mouse model of prodromal Parkinson's disease.

Journal: Experimental neurology

Published: January 07, 2021

Deficits in olfactory sensitivity in a mouse model of Parkinson's disease revealed by plethysmography of odor-evoked sniffing.

Deficits in olfactory sensitivity in a mouse model of Parkinson's disease revealed by plethysmography of odor-evoked sniffing.

Journal: Scientific reports

Published: February 29, 2020

Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits.

Inhibiting the mitochondrial pyruvate carrier does not ameliorate synucleinopathy in the absence of inflammation or metabolic deficits.

Journal: Free neuropathology

Published: January 01, 2020

Serum amyloid P component promotes formation of distinct aggregated lysozyme morphologies and reduces toxicity in Drosophila flies expressing F57I lysozyme.

Serum amyloid P component promotes formation of distinct aggregated lysozyme morphologies and reduces toxicity in Drosophila flies expressing F57I lysozyme.

Journal: PloS one

Published: September 17, 2019

Mapping pathogenic processes contributing to neurodegeneration in Drosophila models of Alzheimer's disease.

Mapping pathogenic processes contributing to neurodegeneration in Drosophila models of Alzheimer's disease.

Journal: FEBS open bio

Published: August 26, 2019

Fire prevention in the Parkinson's disease brain.

Fire prevention in the Parkinson's disease brain.

Journal: Nature medicine

Published: July 11, 2018

Showing 1-12 of 15

Last Updated: 09/26/2026